Results overview: Found 26 records in 0.01 seconds.
Articles, 21 records found
Research literature, 5 records found
Articles 21 records found  1 - 10nextend  jump to record:
1.
34 p, 4.0 MB Development of Small Molecules Targeting α-Synuclein Aggregation : A Promising Strategy to Treat Parkinson's Disease / Peña Díaz, Samuel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Garcia-Pardo, Javier (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Ventura, Salvador (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Parkinson's disease, the second most common neurodegenerative disorder worldwide, is characterized by the accumulation of protein deposits in the dopaminergic neurons. These deposits are primarily composed of aggregated forms of α-Synuclein (α-Syn). [...]
2023 - 10.3390/pharmaceutics15030839
Pharmaceutics, Vol. 15, Issue 3 (March 2023) , art. 839  
2.
4 p, 880.7 KB β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease / Mohaupt, Pablo (Université de Montpellier) ; Pons, Marie-Laure (Université de Montpellier) ; Vialaret, Jérôme (Université de Montpellier) ; Delaby, Constance (Institut d'Investigació Biomèdica Sant Pau) ; Hirtz, Christophe (Université de Montpellier) ; Lehmann, Sylvain (Université de Montpellier) ; Universitat Autònoma de Barcelona
Synaptic degeneration is an early event closely associated with the course of Alzheimer's disease (AD). The identification of synaptic blood biomarkers is, therefore, of great interest and clinical relevance. [...]
2022 - 10.1186/s13195-022-01125-1
Alzheimer's research & therapy, Vol. 14 (november 2022)  
3.
6 p, 6.1 MB Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole Scaffold / Gitto, Rosaria (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Vittorio, Serena (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Bucolo, Federica (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Peña Díaz, Samuel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Siracusa, Rosalba (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Cuzzocrea, Salvatore (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Ventura, Salvador (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Di Paola, Rosanna (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; De Luca, Laura (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences)
Parkinson's disease (PD) is characterized by the death of dopaminergic neurons. The common histopathological hallmark in PD patients is the formation of intracellular proteinaceous accumulations. The main constituent of these inclusions is alpha-synuclein (α-syn), an intrinsically disordered protein that in pathological conditions creates amyloid aggregates that lead to neurotoxicity and neurodegeneration. [...]
2022 - 10.1021/acschemneuro.1c00849
ACS Chemical Neuroscience, Vol. 13, Issue 5 (March 2022) , p. 581-586  
4.
17 p, 1.5 MB A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA) : Rationale, Design, and Baseline Data / Pagano, Gennaro (F Hoffmann-La Roche AG Research and Development Division) ; Boess, Frank (Roche Pharma Research and Early Development) ; Taylor, Kirsten I. (Faculty of Psychology. University of Basel) ; Ricci, Benedicte (Roche Pharma Research and Early Development) ; Mollenhauer, Brit ; Poewe, Werner ; Boulay, Anne ; Anzures-Cabrera, Judith (Roche Products Ltd) ; Vogt, Annamarie ; Marchesi, Maddalena ; Post, Anke ; Nikolcheva, Tania ; Kinney, Gene G. (Prothena Biosciences Inc. South San Francisco) ; Zago, Wagner M. ; Ness, Daniel K. ; Svoboda, Hanno (F. Hoffmann-La Roche) ; Britschgi, Markus ; Ostrowitzki, Susanne ; Simuni, Tanya ; Marek, Kenneth (Institute for Neurodegenerative Disorders) ; Koller, Martin ; Sevigny, Jeff ; Doody, Rachelle ; Fontoura, Paulo ; Umbricht, Daniel ; Bonni, Azad ; Altendorf, Claudia ; Anandan, Chareyna ; Andrews, Giulia ; Ansquer, Solène ; Arrouasse, Raphaele ; Aslam, Sana ; Azulay, Jean-Philippe ; Baker, Jeanette ; Balaguer Martinez, Ernest ; Barbu, Shadi ; Bardram, Kara ; Bega, Danny ; Bejr-kasem, Helena (Institut d'Investigació Biomèdica Sant Pau) ; Benatru, Isabelle ; Benchetrit, Eve ; Bernhard, Felix ; Besharat, Amir ; Bette, Sagari ; Bichon, Amelie ; Billnitzer, Andrew ; Blondeau, Sophie ; Boraud, Thomas ; Borngräber, Freiderike ; Boyd, James ; Brockmann, Kathrin ; Brodsky, Matthew ; Brown, Ethan ; Bruecke, Christof ; Calvas, Fabienne ; Canelo, Monica ; Carbone, Federico ; Carroll, Claire ; Casado Fernandez, Laura ; Cassé-Perrot, Catherine ; Castrioto, Anna ; Catala, Helene ; Chan, Justine ; Cheriet, Samia ; Ciabarra, Aanthony ; Classen, Joseph ; Coleman, Juliana ; Coleman, Robert ; Compta, Yaroslau ; Corbillé, Anne-Gaëlle ; Corvol, Jean-Christophe ; Cosgaya, Marina ; Dahodwala, Nabila ; Damier, Philippe ; David, Elodie ; Davis, Thomas ; Dean, Marissa ; Debilly, Berengere ; DeGiorgio, Janell ; Deik, Andres ; Delaby, Laure ; Delfini, Marie-Helene ; Derkinderen, Pascal ; Derost, Philipp ; de Toledo, María ; Deuel, Lisa ; Diaz-Hernandez, Ann Marie ; Dietiker, Cameron ; Dimenshteyn, Karina ; Dotor, Julio ; Durif, Franck ; Ebentheuer, Jens ; Eggert, Karla Maria ; Eichau Madueño, Sara ; Eickhoff, Claudia ; Ellenbogen, Aaron ; Ellmerer, Philipp ; Esparragosa Vazquez, Inés ; Eusebio, Alexandre ; Ewert, Siobhan ; Fang, John ; Feigenbaum, Danielle ; Fluchere, Frederique ; Foubert-Samier, Alexandra ; Fournier, Marie ; Fradet, Anne ; Fraix, Valerie ; Frank, Samuel ; Fries, Franca ; Galitzky, Monique ; Gallardo Pérez, Marisol ; Moreno, Jose Manuel García ; Gasca, Carmen ; Gasser, Thomas ; Gibbons, Joyce ; Giordana, Caroline ; González Martinez, Alicia ; Goodman, Ira ; Gorospe, Arantza ; Goubeaud, Marie ; Grabli, David ; Graziella, Mangone ; Grimaldi, Stephan ; Gross, Jeffrey ; Guimaraes-Costa, Raquel ; Hartmann, Andreas ; Hartmann, Christian ; Hassell, Travis ; Hauser, Robert ; Hernandez, Antonio ; Hernández-Vara, Jorge ; Hoeglinger, Günter ; Homedes, Christian ; Horta, Andrea ; Houeto, Jean-Luc ; Huebl, Julius ; Hui, Jennifer ; Isaacson, Stuart ; Jankovic, Joseph ; Janzen, Annette ; Jauregui, Junior ; Jiao, Jocelyne ; Martí Domenech, María José ; Joseph, Xavier ; Kadimi, Srinath ; Kaminski, Pat ; Kannenberg, Silja ; Kassubek, Jan ; Katz, Maya ; Klos, Kevin ; Klos, Shannon ; Kobet, Christopher ; Koebert, Jennifer ; Krause, Patricia ; Kuehn, Andrea ; Kulisevsky, Jaime (Institut d'Investigació Biomèdica Sant Pau) ; Kumar, Rajeev ; Kunz, Martin ; Kurvits, Lille ; Kwei, Kimberly ; Laganiere, Simon ; Laurens, Brice ; Levin, Johannes ; Levy, Oren ; LeWitt, Peter ; Cristóbal, Gurutz Linazasoro ; Litvan, Irene ; Lizarraga, Karlo ; Longardner, Katherine ; Lopez, Rocío ; López Manzanares, Lydia ; Lucas del Pozo, Sara ; Luquín Pulido, María Rosario ; Luthra, Nijee ; Lyons, Kelly ; Maass, Sylvia ; Machetanz, Gerrit ; Macías, Yolanda ; Maltete, David ; Manez Miro, Jorge Uriel ; Mariani, Louise-Laure ; Marin, Juan ; Marini, Kathrin ; Marques, Ana ; Marti, Gloria ; Martí Domenech, María José ; Martinez, Saul ; Meissner, Wassilios ; Meoni, Sara ; Mollenhauer, Brit ; Martinez, Dunia Mon ; Moon, Johnson ; Moro, Elena ; Morrison, Peter ; Muehlberg, Christoph ; Multani, Manpreet ; Murphy, Christine ; Nicholas, Anthony ; Pahwa, Rajesh ; Palasí Franco, Antoni ; Pape, Heidi ; Patel, Neepa ; Patel, Prity ; Peball, Marina ; Peckham, Elizabeth ; Peery, Terry ; Perez, Rafael ; Perez, Jesús ; Petit, Alisa ; Pinkhardt, Elmar ; Poewe, Werner ; Pomies, Elsa ; Preterre, Cecile ; Quinn, Joseph ; Rascol, Olivier ; Remy, Philippe ; Richard, Irene ; Roeben, Benjamin ; Ruether, Emily ; Rumpf, Jost-Julian ; Russell, David ; Salhi, Hayet ; Samaniego-Toro, Daniela ; Samier-Foubert, Alexandra ; Sánchez, Antonio ; Schmitt, Emmanuelle ; Schnitzler, Alfons ; Schorr, Oliver ; Schwartzbard, Julie ; Schweyer, Kerstin ; Seppi, Klaus ; Sergo, Victoria ; Shill, Holly ; Siderowf, Andrew ; Simuni, Tanya ; Spampinato, Umberto ; Sriram, Ashok ; Stover, Natividad ; Tanner, Caroline ; Tarakad, Arjun ; Taylor, Carolyn ; Thalamus, Claire ; Toothaker, Thomas ; Van Blercom, Nadege ; Vanegas-Arrogave, Nora ; Vela, Lydia ; Vergnet, Sylvian ; Vidal, Tiphaine ; Vöglein, Jonathan ; Walsh, Ryan ; Waters, Cheryl ; Wegscheider, Mirko ; Weidinger, Endy ; Weill, Caroline ; Wenzel, Gregor ; Witjas, Tatiana ; Wurster, Isabel ; Wright, Brenton ; Zimmermann, Milan ; Zuzuarregui, Rafael ; Abt, Markus ; Bamdadian, Atieh ; Barata, Teresa ; Barbet, Nicholas ; Belli, Sara ; Boess, Frank ; Bonni, Azad ; Borroni, Edilio ; Boulay, Anne ; Britschgi, Markus ; Chague, Jerome ; Cosson, Valerie ; Czech, Christian ; Deptula, Dennis ; Diack, Cheikh ; Doody, Rachelle ; Dukart, Juergen ; D'Urso, Giulia ; Dziadek, Sebastian (F. Hoffmann-La Roche) ; Eddleston, Hannah ; Edgar, Chris ; Essioux, Laurent ; Farell, Morgan ; Finch, Rebecca (Roche Products Ltd) ; Fontoura, Paulo ; Gruenbauer, Waltraud ; Hahn, Andreas ; Holiga, Stefan (F. Hoffmann-La Roche) ; Honer, Michael ; Jadidi, Shirin ; Johnson-Wood, Kelly ; Keller, Markus ; Kilchenmann, Timothy ; Koller, Martin ; Kremer, Thomas ; Kustermann, Thomas (F. Hoffmann-La Roche) ; Landsdall, Claire ; Lindemann, Michael (F. Hoffmann-La Roche) ; Lipsmeier, Florian ; Luzy, Cecile ; Manchester, Marianne ; Marchesi, Maddalena ; Martenyi, Ferenc ; Martin-Facklam, Meret ; Mironova, Katerina ; Monnet, Annabelle (F. Hoffmann-La Roche) ; Moore, Emma ; Ness, Daniel K. ; Niggli, Markus ; Nikolcheva, Tania (F. Hoffmann-La Roche) ; Ostrowitzki, Susanne ; Passmard, Benedicte ; Poirier, Agnes ; Post, Anke ; Prasad, Megana ; Pross, Nathalie (F. Hoffmann-La Roche) ; Quock, Tiffany ; Rose, Ellen ; Sarry, Christoph ; Schubert, Christine ; Selkoe, Dennis ; Sevigny, Jeff ; Sink, Kaycee ; Staunton, Hannah ; Steven, Tim ; Strasak, Alexander ; Svoboda, Hanno ; Tripuraneni, Radhika ; Trundell, Dylan ; Umbricht, Daniel ; Verselis, Lynne ; Vogt, Annamarie ; Volkova-Volkmar, Ekaterina ; Weber, Cornelia ; Weber, Silke ; Zago, Wagner (Prothena Biosciences Inc. (San Francisco))
Background: Currently available treatments for Parkinson's disease (PD) do not slow clinical progression nor target alpha-synuclein, a key protein associated with the disease. Objective: The study objective was to evaluate the efficacy and safety of prasinezumab, a humanized monoclonal antibody that binds aggregated alpha-synuclein, in individuals with early PD. [...]
2021 - 10.3389/fneur.2021.705407
Frontiers in neurology, Vol. 12 (january 2021) , p. 705407  
5.
14 p, 3.0 MB Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation / De Luca, Laura (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Vittorio, Serena (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Peña Díaz, Samuel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Pitasi, Giovanna (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Fornt Suñé, Marc (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Bucolo, Federica (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences) ; Ventura, Salvador (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Gitto, Rosaria (University of Messina. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences)
α-Synuclein (α-Syn) aggregates are implicated in Parkinson's disease (PD), so inhibitors of α-Syn aggregation have been intensively explored. It has been demonstrated that small molecules might be able to reduce α-Syn aggregation in fibrils, thus exerting neuroprotective effects in models of PD. [...]
2022 - 10.3390/ijms232314844
International journal of molecular sciences, Vol. 23, Issue 23 (November 2022) , art. 14844  
6.
11 p, 2.5 MB The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains / Peña Díaz, Samuel (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Pujols Pujol, Jordi (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Vasili, Eftychia (Max Planck Institute for Experimental Medicine) ; Pinheiro, Francisca (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Santos, Jaime (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Manglano-Artuñedo, Zoe (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Outeiro, Tiago Fleming (Scientific Employee With a Honorary Contract. Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)) ; Ventura, Salvador (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí")
Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, as well as the accumulation of intraneuronal proteinaceous inclusions known as Lewy bodies and Lewy neurites. [...]
2022 - 10.1016/j.jbc.2022.101902
Journal of biological chemistry, Vol. 298, Issue 5 (May 2022) , art. 101902  
7.
25 p, 864.4 KB The Emerging Role of the Lysosome in Parkinson's Disease / Navarro-Romero, Alba (Universitat Autònoma de Barcelona) ; Montpeyó Garcia-Moreno, Marta (Universitat Autònoma de Barcelona) ; Martinez-Vicente, Marta (Universitat Autònoma de Barcelona)
Lysosomal function has a central role in maintaining neuronal homeostasis, and, accordingly, lysosomal dysfunction has been linked to neurodegeneration and particularly to Parkinson's disease (PD). Lysosomes are the converging step where the substrates delivered by autophagy and endocytosis are degraded in order to recycle their primary components to rebuild new macromolecules. [...]
2020 - 10.3390/cells9112399
Cells, Vol. 9 (november 2020)  
8.
15 p, 2.7 MB Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease / Marsal-García, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Campdelacreu, Jaume (Hospital Universitari de Bellvitge) ; Vilas, Dolores (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ispierto, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gascon-Bayarri, Jordi (Hospital Universitari de Bellvitge) ; Reñé, Ramón (Hospital Universitari de Bellvitge) ; Álvarez, Ramiro (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Beyer, Katrin (Institut Germans Trias i Pujol) ; Urbizu, Aintzane (Institut Germans Trias i Pujol) ; Arnaldo, Laura (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Lewy body diseases (LBD) including dementia with Lewy bodies (DLB) and Parkinson disease (PD) are characterized by alpha-synuclein pathology. DLB is difficult to diagnose and peripheral biomarkers are urgently needed. [...]
2021 - 10.3390/ijms22020725
International journal of molecular sciences, Vol. 22 Núm. 2 (2021) , p. 725  
9.
12 p, 2.4 MB Inhibition of α-synuclein aggregation and mature fibril disassembling with a minimalistic compound, ZPDm / Peña Díaz, Samuel (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Pujols Pujol, Jordi (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Pinheiro, Francisca (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Santos, Jaime (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Pallarès i Goitiz, Irantzu (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Navarro, Susanna (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Conde Giménez, María (Universidad de Zaragoza. Instituto Aragonés de Investigaciones Sanitarias) ; García, Jesús (Institut de Recerca Biomèdica de Lleida) ; Salvatella, Xavier (Institució Catalana de Recerca i Estudis Avançats) ; Dalfo, Esther (Universitat Autònoma de Barcelona. Facultat de Medicina) ; Sancho, Javier (Universidad de Zaragoza. Instituto Aragonés de Investigaciones Sanitarias) ; Ventura, Salvador (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
Synucleinopathies are a group of disorders characterized by the accumulation of α-Synuclein amyloid inclusions in the brain. Preventing α-Synuclein aggregation is challenging because of the disordered nature of the protein and the stochastic nature of fibrillogenesis, but, at the same time, it is a promising approach for therapeutic intervention in these pathologies. [...]
2020 - 10.3389/fbioe.2020.588947
Frontiers in Bioengineering and Biotechnology, Vol. 8 (October 2020) , art. 588947  
10.
20 p, 1.6 MB Autophagic- and Lysosomal-Related Biomarkers for Parkinson's Disease : Lights and Shadows / Xicoy, Helena (Department of Molecular Animal Physiology, Donders Institute for Brain, Cognition and Behaviour, Donders Centre for Neuroscience, Faculty of Science, 6525 GA Nijmegen, The Netherlands) ; Peñuelas, Núria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vila Bover, Miquel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Laguna, Ariadna (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Parkinson's disease (PD) is a neurodegenerative disorder that currently affects 1% of the population over the age of 60 years, for which no disease-modifying treatments exist. This lack of effective treatments is related to the advanced stage of neurodegeneration existing at the time of diagnosis. [...]
2019 - 10.3390/cells8111317
Cells, Vol. 8 (october 2019)  

Articles : 21 records found   1 - 10nextend  jump to record:
Research literature 5 records found  
1.
19.9 MB Structural biology of α-synuclein toxic oligomers : Design of peptide ligands and architecture elucidation / Santos, Jaime ; Pallarès i Goitiz, Irantzu, dir. ; Ventura Zamora, Salvador, dir.
L'agregació de l'alfa-sinucleïna (αS) és la principal característica neurològica d'un grup de trastorns neurodegeneratius debilitants, coneguts col·lectivament com a sinucleinopaties, dels quals la malaltia de Parkinson és la més freqüent. [...]
La agregación de la alfa-sinucleína (αS) es la principal característica neurológica de un grupo de trastornos neurodegenerativos debilitantes, conocidos colectivamente como sinucleinopatías, de los cuales la enfermedad de Parkinson es la más frecuente. [...]
α-Synuclein (αS) aggregation is the main neurological hallmark of a group of debilitating neurodegenerative disorders, collectively referred to as synucleinopathies, of which Parkinson's disease is the most prevalent. [...]

2023  
2.
2 p, 11.0 MB Oligomeric alpha synuclein : a hallmark in Parkinson's disease diagnosis / Macián Nicolás, Andrea ; Universitat Autònoma de Barcelona. Facultat de Biociències
2021
Grau en Genètica [833]  
3.
2 p, 634.9 KB Gut microbiota involvement in α-synuclein pathology and Parkinson's disease / Moro Buendia, Marc ; Universitat Autònoma de Barcelona. Facultat de Biociències
2021
Grau en Microbiologia [816]  
4.
192 p, 8.9 MB Initiation, progression and extension of parkinson's disease: role of α-synuclein / Recasens Ibabe, Ariadna ; Vila Bover, Miquel, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
La malaltia de Parkinson és un trastorn neurodegeneratiu freqüent d'origen desconegut que es caracteritza principalment per la pèrdua de neurones dopaminèrgiques de la substància nigra pars compacta (SNpc) i la presencia d'inclusions proteiques intacitoplasmàtiques anomenades cossos de Lewy (CL), en diverses regions cerebrals afectades. [...]
Parkinson's disease (PD) is a common neurodegenerative disorder of unknown origin mainly characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the presence of intraneuronal proteinaceous cytoplasmic inclusions, called Lewy bodies (LB), in several affected brain areas. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  
5.
1 p, 1.1 MB Characterization of α-synuclein and histone H1 interaction and its potential role as therapeutic target in treatment of Parkinson's disease / Gómez, Carlota ; Roque Córdova, Alicia, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Bioquímica [814]  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.